“Will & Grace” star Corey Parker has died. He was 60 years old. The actor’s aunt, Emily Parker, revealed the actor died on Thursday in Memphis, Tenn., following a battle with cancer, reports TMZ. It ...
Marty Makary, commissioner of the Food and Drug Administration, speaks at the White House on Sept. 22. (Mark Schiefelbein/AP) Marty Makary appeared Thursday for an interview on CNBC to tout efforts ...
Shares in USA Rare Earth (NASDAQ: USAR) rose by 16.2% in the week to Friday morning. The move comes in a week when the company released exciting investor presentations on its website that provided ...
The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...
USA Rare Earth recently announced two separate funding deals: one from the U.S. government and the other from private investors. The deals will help fund USA Rare Earth at a critical time, but come at ...
SUMTER COUNTY, S.C. — Less than two years after breaking ground, eVAC Magnetics turned a soybean field into a manufacturing facility and has shipped its first rare-earth permanent magnets for ...
The FDA in October 2025 granted bitopertin its Commissioner’s National Priority Voucher but after a shortened review time has decided the data did not support regulatory approval for treating ...
Retired General Jack Keane has joined REalloys’ board, signaling that rare-earth metallization is now being treated as a core national security priority, not just an industrial issue. The ...
USA Rare Earth is trying to build a supply chain of rare-earth magnets on U.S. soil. The pre-revenue company controls one of the most significant rare-earth deposits in the U.S. The company has ...
Researchers have identified the exact viral component and genetic conditions that explain an ultrarare clotting complication associated with adenoviral vaccines. By uncovering the specific immune ...
Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results